Developing a Vaccine Against Multiple Psychoactive Targets: A Case Study of Heroin
Authors:
- 1 December 2011
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 10 (8) , 865-875
Abstract
Heroin addiction is a wide-reaching problem with a spectrum of damaging social consequences. Currently approved heroin addiction medications include drugs that bind at the same receptors (e.g. opioid receptors) occupied by heroin and/or its metabolites in the brain, but undesired side effects of these treatments, maintenance dependence and relapse to drug taking remains problematic. A vaccine capable of blocking heroin's effects could provide an economical, long-lasting and sustainable adjunct to heroin addiction therapy without the side effects associated with available treatment options. Heroin, however, presents a particularly challenging vaccine target as it is metabolized to multiple psychoactive molecules of differing lipophilicity, with differing abilities to cross the blood brain barrier. In this review, we discuss the opiate scaffolding and hapten design considerations to confer immunogenicity as well as the specificity of the immune response towards structurally similar opiates. In addition, we detail different strategies employed in the design of immunoconjugates for a vaccine-based therapy for heroin addiction treatment.Keywords
This publication has 81 references indexed in Scilit:
- A Vaccine Strategy that Induces Protective Immunity against HeroinJournal of Medicinal Chemistry, 2011
- Escalation patterns of varying periods of heroin accessPharmacology Biochemistry and Behavior, 2011
- Impact of Distinct Chemical Structures for the Development of a Methamphetamine VaccineJournal of the American Chemical Society, 2011
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- Drugs of Abuse That Mediate Advanced Glycation End Product Formation: A Chemical Link to Disease PathologyAccounts of Chemical Research, 2009
- The discovery of heroinThe Lancet, 1998
- Morphine Modulates NFκB Activation in MacrophagesBiochemical and Biophysical Research Communications, 1998
- Is AIDS a disease of poverty?AIDS Care, 1996
- Species difference of site-selective glucuronidation of morphine.Journal of Pharmacobio-Dynamics, 1991
- Evidence from opiate binding studies that heroin acts through its metabolitesLife Sciences, 1983